Beyond scaled customers, our new logo additions from our ... In partnership with SAP, a global fashion brand increased its business with Vertex due to a global cloud transformation initiative.

SAP's journey began in 1972 when five former IBM employees founded the company in Germany. Initially focused on business ...

Nonprofit organizations utilizing the latest ezCheckprinting and virtual printer software no longer need be concerned about ...

By Lucy Raitano and Samuel Indyk LONDON (Reuters) -German software company SAP overtook Danish healthcare company Novo ...

Morgan Stanley raised the firm’s price target on Vertex (VERX) to $60 from $57 and keeps an Overweight rating on the shares. The company’s ...

KING OF PRUSSIA, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) today announced that it will host an Investor Day on Wednesday, March 19, in Philadelphia, PA. The event will ...

Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

We are a city that drives innovation — where the scientists at Vertex invented life-changing ... Four years ago, businesses like Eli Lilly, SAP, Roche, LEGO, and NVIDIA called other cities ...

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $503.20, representing a -1.37% change from its previous close. Amicus Therapeutics (FOLD) reported earnings 30 days ago.

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...